Prognostic Accuracy of Serially Measured Organ Dysfunction Scores in Children with Fluid Refractory Septic Shock

Ritu Sharma1, Arpita Chattopadhyay2, Diganta Saikia1

  • 1Department of Pediatrics, Chacha Nehru Bal Chikitsalaya, Geeta Colony, New Delhi, 110031, India.

Indian Pediatrics
|April 1, 2026
PubMed

Insights

Serial assessment of PEdiatric Logistic Organ Dysfunction (PELOD)-2 and pediatric Sequential Organ Failure Assessment (pSOFA) scores improves prediction of mortality in pediatric septic shock. The PELOD-2 score showed higher accuracy, particularly on day 4 of pediatric intensive care unit admission.

Area of Science:

  • Pediatric critical care medicine
  • Septic shock research
  • Prognostic scoring systems

Background:

  • Pediatric septic shock carries a high mortality risk.
  • Accurate prognostic tools are crucial for timely intervention.
  • Fluid-refractory septic shock presents unique management challenges.

Purpose of the Study:

  • To compare the prognostic accuracy of serially measured PELOD-2 and pSOFA scores.
  • To evaluate their ability to predict 28-day in-hospital mortality.
  • To assess score performance in pediatric fluid-refractory septic shock.

Main Methods:

  • Prospective enrollment of children (<12 years) with fluid-refractory septic shock.
  • Serial calculation of PELOD-2 and age-adapted pSOFA scores over 4 days.
  • Comparison of scoring systems using Area Under the Receiver Operating Characteristic Curve (AUROC) analysis.

Main Results:

  • The sensitivity of PELOD-2 for mortality prediction increased from 60.5% on day 1 to 84.2% on day 4.
  • pSOFA sensitivity rose from 47.4% to 63.2% over the same period.
  • Both scores showed improved discriminative power over time, with adjusted AUROC for PELOD-2 reaching 0.90 on day 4.

Conclusions:

  • Serially assessed PELOD-2 and pSOFA scores enhance prognostic accuracy for 28-day mortality in pediatric septic shock.
  • Prognostic performance significantly improves when scores are assessed on day 4 versus admission.
  • PELOD-2 demonstrated superior discriminative ability compared to pSOFA in this cohort.
Abstract